Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Oral collagen combined with other treatments effectively reduces hair loss and improves hair quality in telogen effluvium.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Glass ceiling syndrome is linked to stress-related hair loss in female healthcare workers.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Ferritin and vitamin B12 deficiencies are common causes of hair loss in women aged 18-45.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Telogen effluvium is hair loss caused by disruption of the normal hair cycle.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.